Elizabeth Becerra
Internal Medicine · Berwyn, ILNPI 1376560102
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 390 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 17.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,938 and has fallen 99.4% since, to $19 in 2025. Among internal medicine clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 390 payments — averaging $18.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Novo Nordisk$1K
- Lilly USA, LLC$755
- Sanofi-aventis U.S. LLC$620
- Pfizer$552
- Boehringer Ingelheim$542
- plus $2K from 19 others
What the payments were for
- Food & beverage$7,19799%
- Education$821%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 61 | $1,266 |
| Novo Nordisk | 59 | $1,060 |
| Lilly USA, LLC | 43 | $755 |
| Sanofi-aventis U.S. LLC | 31 | $620 |
| Pfizer | 26 | $552 |
| Boehringer Ingelheim | 28 | $542 |
| Merck | 37 | $510 |
| Amarin Pharma, Inc. | 23 | $383 |
| Johnson & Johnson | 15 | $288 |
| AbbVie(2 entities) | 13 | $214 |
| GSK | 5 | $191 |
| Amgen(2 entities) | 8 | $172 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $143 |
| Ironwood Pharmaceuticals, Inc | 7 | $111 |
| Nestle Healthcare Nutrition Inc. | 4 | $94 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $83 |
| Dexcom, Inc. | 5 | $75 |
| Vivus LLC | 3 | $62 |
| Astellas Pharma US Inc | 3 | $48 |
| Lupin Inc. | 2 | $26 |
| Abbott | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Phadia US Inc. | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$242
- Ozempic$121
- SOLIQUA 100/33$101
How this compares
$7,280 in reported general payments places this provider in the 90th percentile of 5,182 internal medicine providers in Illinois.
Other internal medicine in Berwyn
- Zaid JabbarOak Brook$1.2M
- Merle DiamondChicago$1.1M
- David ReckerLibertyville$868K
- Yazen JoudehOrland Park$661K
- Robert KushnerChicago$516K
- William CruikshankOak Lawn$431K
- Romeo UrsuaChicago$420K
- Shaina RozellChicago Ridge$366K
- Kristi Tough DesapriWinnetka$344K
- Peter O DonnellChicago$318K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.